Amended Quarterly Report (10-q/a)

Date : 11/15/2018 @ 9:20PM
Source : Edgar (US Regulatory)
Stock : InventaBioTech Inc. (INVB)
Quote : 0.0255  0.0 (0.00%) @ 1:23PM

Amended Quarterly Report (10-q/a)

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

(Amendment Number 1)

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly period ended  September 30, 2018

 

[] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

     SECURITIES EXCHANGE ACT OF 1934

 

Commission File No.  0-53030

 

WESTMOUNTAIN COMPANY

(Exact Name of Issuer as specified in its charter)

 

Colorado   26-1315305
(State or other Jurisdiction of Incorporation)   (IRS Employer Identification Number)

 

3463 Magic Drive, Suite 120
San Antonio, TX 78229
(Address of principal executive offices, including zip code)

 

(210) 767-2727

(Registrant’s telephone number including area code)

 

(Former Name or Former Address, if Changed Since the Last Report)

 

Indicate by check mark whether the registrant: (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes [X]  No [ ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).. Yes [X] No [ ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or, an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company", and "emerging growth company", in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  [ ]   Accelerated filer  [ ]
Non-accelerated filer   [ ]   Smaller reporting company  [X]
(Do not check if smaller reporting company)   Emerging growth company  [ ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [ ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes []    No [X]

 

The number of shares outstanding of the registrant's common stock, as of the latest practicable date, November 1, 2018, was 54,798,761.

 

 

 

   
 

 

 

 

EXPLANATORY NOTE

The sole purpose of this Amendment No. 1 to WestMountain Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2018, originally filed with the Securities and Exchange Commission on November 14, 2018, is to file Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 to this Amendment No. 1 provides the consolidated financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).

No other changes have been made to the Form 10-Q. This Amendment No. 1 speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original filing of the Form 10-Q.

 

 

 

  2  
 

 

 

 

ITEM 6.  EXHIBITS

 

 

Exhibit    
Number   Description
     
31.1   Certification of CEO pursuant to Sec. 302
     
31.2   Certification of CFO pursuant to Sec. 302
     
32.1*   Certification of CEO/CFO pursuant to Sec. 906
     
101.INS   XBRL Instance Document.
     
101.SCH   XBRL Taxonomy Extension Schema Document.
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document.

 

* In accordance with SEC Release 33-8238, Exhibit 32.1 is being furnished and not filed.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized November 15, 2018.

 

  WESTMOUNTAIN COMPANY
   
   By: /s/ James R. Garvin
  James R. Garvin, Chief Executive Officer and (Principal Executive Accounting Officer)
   
  By: /s/ Brian Zucker
  Brian Zucker, Chief Financial Officer (Principal Financial and Principal Accounting Officer)
   

 

 

  3  
 

InventaBioTech Inc. (USOTC:INVB)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more InventaBioTech Inc. Charts.

InventaBioTech Inc. (USOTC:INVB)
Intraday Stock Chart

Today : Saturday 20 July 2019

Click Here for more InventaBioTech Inc. Charts.

Latest INVB Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.